简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2017-06-27 13:46 Herbalife Nutrition Encourages North Asia Members to Play a Bigger Role in Inspiring Healthy Active Living in Their Local Communities
2017-06-26 13:47 Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma Patients and in the Maintenance Setting
2017-06-26 10:52 Bionext Launches Biosight: an Online Platform That Will Revolutionize Pharmaceutical Research
2017-06-22 10:04 New Study Compares Performance of Masimo Next Generation SedLine® Patient State Index (PSi) to Original PSi During Anesthesia
2017-06-21 17:08 New data reveal high rates of stroke history in asymptomatic atrial fibrillation patients
2017-06-20 15:07 Pacific Prime Joins Worldwide Broker Network as Newest Asia Pacific Region Member
2017-06-20 13:14 Hiroshima International University Releases "Cheatable Exam?"
2017-06-20 09:56 First-Ever World Kidney Cancer Q&A Day Highlights Growing Global Burden
2017-06-16 14:59 Merck Becomes Member of the Worldwide Innovative Network in Personalized Cancer Medicine - WIN Consortium (Paris)
2017-06-16 11:03 SERMO Announces Massive Global Expansion, Now Available in More Than 150 Countries
2017-06-15 10:00 Boehringer Ingelheim presents phase III results demonstrating clinical equivalence of adalimumab biosimilar candidate to HUMIRA®
2017-06-15 09:58 Phase 2a Safety and Efficacy Data Support Further Development of Oral CC-220 in Patients with Lupus
2017-06-15 09:55 Pimodivir Alone or in Combination with Oseltamivir Demonstrated a Significant Reduction in Viral Load in Adults with Influenza A
2017-06-14 10:59 Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery
2017-06-14 10:56 FX Creations’ Spacewalker 2nd Generation Backpack
2017-06-13 15:21 New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™
2017-06-12 15:10 Mannatech Finds Most Aloe Vera Products Are Missing This Key Feature That Makes the Difference to Your Health
2017-06-09 14:07 Updated Data from Phase 1 Trial of Oral IDHIFA® (enasidenib) Demonstrate Complete Responses and Duration of Response in Patients with Relapsed or Refractory AML and an IDH2 Mutation
2017-06-08 10:06 Takeda and Seattle Genetics Announce Lancet Publication of Phase 3 ALCANZA Clinical Trial Data of ADCETRIS® (Brentuximab Vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma
2017-06-07 18:21 Claret Medical Receives FDA Clearance to Market Sentinel Cerebral Protection System in the U.S.

Business Wire Weibo

Press Releases

Latest Releases